Pura Vida Investments’s Lucira Health, Inc. Common Stock LHDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-690,663
Closed -$1.28M 273
2022
Q2
$1.28M Buy
690,663
+3,450
+0.5% +$8.38K 0.07% 156
2022
Q1
$2.45M Sell
687,213
-478,017
-41% -$2.35M 0.08% 153
2021
Q4
$10M Buy
1,165,230
+163,288
+16% +$1.04M 0.36% 73
2021
Q3
$7.62M Buy
1,001,942
+601,942
+150% +$5.08M 0.23% 117
2021
Q2
$2.66M Buy
+400,000
New +$2.52M 0.08% 145

Other funds holding LHDX

Pura Vida Investments's LHDX Position: Q3 2022 in Review

Pura Vida Investments sold out of Lucira Health, Inc. Common Stock (LHDX) in Q3 2022, closing a stake of 690,663 shares — an estimated $1.28M sold.

Pura Vida Investments first reported a position in LHDX in Q2 2021 and held it in 5 quarters. The position peaked at $10M in Q4 2021. 28 funds tracked by Wall St. Rank hold LHDX as of Q3 2022.

  • Pura Vida Investments reported no remaining Lucira Health, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Pura Vida Investments sold 690,663 Lucira Health, Inc. Common Stock shares in Q3 2022, an estimated $1.28M.
  • Pura Vida Investments first reported a position in Lucira Health, Inc. Common Stock in Q2 2021 and held it in 5 quarters.
  • Pura Vida Investments's Lucira Health, Inc. Common Stock position peaked at $10M in Q4 2021.
  • 28 funds tracked by Wall St. Rank held Lucira Health, Inc. Common Stock as of Q3 2022.

Based on Pura Vida Investments's 13F filing for Q3 2022, filed 14 Nov 2022.